Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Tria...( American Association for Cancer R...),Health

American Association for Cancer Research Aims to Raise Awareness about the Importance of Clinical Trial Participation

PHILADELPHIA, Sept. 24 /PRNewswire/ --

News facts:

-- Most Americans with cancer would be receptive to participating in

clinical trials if they knew about them.

-- In a survey of 6,000 cancer patients, 85 percent were either unaware

or unsure that participation in a clinical trial was an option.

Seventy-five percent said they would have been willing to enroll had

they known it was possiblei.

-- This lack of knowledge is leading to a crisis in cancer drug

development with 80 percent of clinical trials in the U.S. being

delayed because of unfulfilled enrollmentii.

-- While clinical trials remain the only way to effectively test potential

new medications, fewer than 5 percent of adult cancer patients

participate in themiii. This lack of participation leads to delays in

clinical trials and slows patient access to new and possibly lifesaving

treatment options.

-- The American Association for Cancer Research (AACR), the proud

scientific partner of Stand Up to Cancer, a ground-breaking initiative

aimed at raising funds to accelerate cancer research and bringing new

therapies to patients more quickly, is committed to spreading knowledge

about cancer research and is on the front lines of the quest for

prevention and cure. AACR is taking a lead in raising awareness about

the urgent need to increase cancer clinical trial participation.

-- Clinical trials are not for everyone, but if you have been diagnosed

with any type of cancer, talk to your doctor about whether a clinical

trial may be right for you.

-- For information about AACR's progress toward the prevention and

cu
'/>"/>